Art. 5 Commission Delegated Regulation (EU) No 1252/2014 of 28 May 2014 supplementing Directive…

Buildings and facilities

In forcesince 28 May 2014
1.

Buildings and facilities used in the manufacturing of active substances shall be located, designed and constructed to suit the intended operations and to facilitate cleaning and maintenance having regard to the type and stage of manufacturing which the buildings and facilities are used for.

Facilities and the flow of material and personnel through the facilities shall be designed to ensure that different substances and materials are kept separate and do not contaminate each other.

2.

Buildings shall be properly maintained and repaired and kept in a clean condition.

3.

Highly sensitising active substances shall be produced in separate production areas.

When carrying out production operations, the manufacturer shall assess the need for separate production areas for other active substances with the potential to be harmful to human health because of their potency or their infective or toxic nature. The assessment shall evaluate the risk to human health posed by those active substances by taking account of the active substance potency, toxicity, infectivity and the risk minimisation procedures in place. The assessment shall be documented in writing.

Where the assessment shows a risk of harm to human health, the active substance shall be produced in separate production areas.